Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus spironolactone plus topical clindamycin for acne vulgaris
IRCT20260601069601N1Phase 3Recruiting
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in acne vulgaris comparing Metformin and topical clindamycin with Spironolactone and topical clindamycin (2 arms). Primary endpoint: Number of acne vulgaris lesions. Started Jul 2026; status: recruiting.
02
Drugs
metforminspironolactoneclindamycin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on IRCT20260601069601N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260601069601N1.